חזרה לתוצאות החיפוש

A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Recurrent Medulloblastoma · Refractory Medulloblastoma · CNS Metastases · Central Nervous System Metastasis

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Memorial Sloan Kettering Cancer Center Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Sameer Farouk Sait, MBBS) · 212-639-2153

  • Memorial Sloan Kettering at Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

    Contact: Study coordinator (Sameer Farouk Sait, MBBS) · 212-639-2153

  • Memorial Sloan Kettering at Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

    Contact: Study coordinator (Sameer Farouk Sait, MBBS) · 212-639-2153

  • Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities), Commack, New York, United States

    Contact: Study coordinator (Sameer Farouk Sait, MBBS) · 212-639-2153

  • Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison, New York, United States

    Contact: Study coordinator (Sameer Farouk Sait, MBBS) · 212-639-2153

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

    Contact: Study coordinator (Sameer Farouk Sait, MD) · 212-639-2153

  • Memorial Sloan Kettering at Nassau (Limited Protocol Activities), Uniondale, New York, United States

    Contact: Study coordinator (Sameer Farouk Sait, MBBS) · 212-639-2153
מובילי המחקר

  • Sameer Farouk Sait, MBBS

    Principal Investigator

    Memorial Sloan Kettering Cancer Center

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)